|
SPATA6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.71299999999608E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.045500E-04 |
| Normal-vs-Stage2 |
8.789500E-04 |
| Normal-vs-Stage3 |
1.360290E-04 |
| Normal-vs-Stage4 |
1.757210E-03 |
| Stage1-vs-Stage2 |
5.286600E-01 |
| Stage1-vs-Stage3 |
3.336200E-01 |
| Stage1-vs-Stage4 |
5.442200E-01 |
| Stage2-vs-Stage3 |
8.451800E-01 |
| Stage2-vs-Stage4 |
7.450800E-01 |
| Stage3-vs-Stage4 |
8.494200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.214480E-04 |
| Normal-vs-AfricanAmerican |
1.834220E-04 |
| Normal-vs-Asian |
5.560600E-04 |
| Caucasian-vs-AfricanAmerican |
4.941600E-01 |
| Caucasian-vs-Asian |
4.788100E-02 |
| AfricanAmerican-vs-Asian |
2.663800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.5861000000349E-06 |
| Normal-vs-Female |
9.902300E-02 |
| Male-vs-Female |
1.826220E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.373600E-04 |
| Normal-vs-Extreme_Weight |
1.954840E-04 |
| Normal-vs-Obese |
2.263000E-03 |
| Normal-vs-Extreme_Obese |
1.044630E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.602400E-01 |
| Normal_Weight-vs-Obese |
4.056600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.295000E-01 |
| Extreme_Weight-vs-Obese |
3.530000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.080800E-01 |
| Obese-vs-Extreme_Obese |
3.053800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.502600E-03 |
| Normal-vs-Age(41-60Yrs) |
9.016300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.8737000000435E-06 |
| Normal-vs-Age(81-100Yrs) |
9.775800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.512000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.187600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.997200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.396500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.427400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.920000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.786100E-04 |
| Normal-VS-Type2 PRCC |
1.70441999999271E-05 |
| Normal-VS-KIRP CIMP |
2.277500E-03 |
| Normal-VS-Unclassified PRCC |
4.937600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.907770E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.355200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.741200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.854200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.134000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.436000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.66020000028178E-07 |
| Normal-vs-N1 |
6.791200E-04 |
| Normal-vs-N2 |
1.460620E-01 |
| N0-vs-N1 |
2.772600E-01 |
| N0-vs-N2 |
3.933800E-01 |
| N1-vs-N2 |
7.446600E-01 |
|
|
